Concerns Over Health Risks from Proton Pump Inhibitors Persist

Posted by Anapol Weiss on Aug 31, 2016 11:06:39 AM

Labor Day weekend is right around the corner.  For some people that means cookouts, barbeques, spicy dips, and cocktails. And for sufferers of acid reflux, also known as Gastroesophageal Reflux Disease (GERD), that’s a holiday menu that’s sure to end with plenty of discomfort.

That’s why so many with GERD have turned to proton pump inhibitors (PPIs) that treat acid reflux by reducing the production of stomach acid. Brand name PPIs include Nexium, Prevacid, Prilosec, and Protonix.

The problem is, at the beginning of the year studies showed PPI use to be associated with a greater risk for chronic kidney disease.

At Anapol Weiss, the Unsafe Drugs team led by Tracy Finken has been working on educating consumers about 430_P_Anapol_Weiss_Lawfirm-567782-edited.jpgthe dangers of long term PPI use and are making sure patients harmed by the use of PPIs have their stories heard.

If you’ve been using PPIs long term and want to know more about the risks and your rights as a patient, contact Tracy Finken with any questions.

Topics: PPI

New Mass Tort Spotlight: Proton Pump Inhibitors

Posted by Anapol Weiss on Jun 13, 2016 3:54:51 PM

Proton_Pump_Inhibitors.jpgAfter release of an alarming January 2016 study linking chronic kidney disease (CKD), to proton pump inhibitors (PPIs) Anapol Weiss began to take on Nexium, Protonix, Prilosec and Prevacid. These popular stomach acid reducers have a potentially deadly side effect.

An estimated 15 million Americans take prescription PPIs, and the drugs are also available over-the-counter. PPIs block the production of stomach acid and are commonly taken to treat gastroesophageal reflux disease (GERD), heart burn, peptic or stomach ulcers, and damage to the lower esophagus caused by acid reflux.

As leaders in national dangerous drug litigations, the attorneys at Anapol Weiss will continue to pursue the details on behalf of CKD victims who took PPI drugs for an extended period of time.

CKD involves the gradual loss of kidney function. A patient must undergo dialysis or a kidney transplant if the condition progresses to end-stage kidney failure. A second study published in April 2016 also linked PPI drugs to a higher risk of CKD. Using data from the U.S. Department of Veterans Affairs, a second set of researchers found patients who took PPIs had a 96 percent increased risk of kidney failure and a 28 percent increased risk of developing CKD – when compared to patients who took histamine H2 receptor blockers instead.

Topics: PPI

What is End-Stage Renal Disease?

Posted by Anapol Weiss on Feb 15, 2016 3:30:00 PM

Chronic kidney disease (CKD) involves the gradual loss of kidney function – the process responsible for filtering waste and excess water from the blood. When patients are diagnosed with end-stage kidney disease or end-stage renal disease (ESRD), their kidneys are not functioning well enough on their own to meet the needs of daily life. Patients with ESRD have less than 10 to 15 percent of normal kidney function.

ESRD.jpgA physician may perform one or more of the following tests to diagnose ESRD:

  • Blood test
  • Urine test
  • Renal ultrasound
  • Kidney biopsy
  • Computed tomography scan (CT scan)

Patients with ESRD or severe symptoms often undergo dialysis either at a center or in their home. Dialysis takes over kidney function by removing waste and fluid from the blood. Laboratory tests will help patients and their physicians decide when dialysis should begin. Dialysis does not cure ESRD, but it helps patients feel better and live longer, according to Johns Hopkins Medicine.

Some patients with ESRD undergo kidney transplant surgery. While dialysis is not a cure for ESRD, a new kidney can take over the function of the failed kidneys. Patients who undergo a kidney transplant will need to take medication for the rest of their lives in order to keep the transplanted kidney healthy, the University of California San Francisco Medical Center explains.

When ESRD Could Have Been Prevented

Two population-based analyses published in January 2016 have associated a class of stomach acid drugs called proton pump inhibitors (PPIs) with an increased risk of CKD. PPIs reduce the production of acid made by the stomach glands and include brand names such as Prevacid and Nexium.

Patients who took PPI drugs and developed kidney disease could now be facing ESRD. They would have likely made a different decision with their physician about their medication had they been warned of these dangers, but now it’s too late.

Contact our firm for assistance if you took a PPI drug over an extended period of time and are suffering from severe or end-stage kidney disease. We can investigate your situation and answer any legal questions you have.

Topics: Proton Pump Inhibitors, PPI

Subscribe to The Anapol Weiss Blog